BioWorld

Jan. 23, 2009

Study Finds Nondevelopmental Gene Critical for Neural Repair

Axikin Emerges as New Spinout to Pursue Respiratory Drugs

Following Actimis Pharmaceuticals Inc.'s structured buyout deal last June, the San Diego-based firm's investors decided to back a spinout venture with the company's remaining assets, forming Axikin Pharmaceuticals Inc. (BioWorld Today) Read More

Akesis Latest U.S. Biotech Firm to Face Bankruptcy

NewCo News: Asphelia Tackles 'Yuck Factor' of Helminth Egg-Based Drugs

Corrections & Clarifications

Lytix Adds $10M for Peptide Drugs to Treat Infectious Diseas

Other News To Note

U.S. Patent Disclosures

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for June 5, 2026.

ASCO 2026: A revolution in pancreatic cancer

BioWorld

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

EASL 2026: Emerging liver disease targets to watch

BioWorld

At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...

Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

BioWorld

Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...